FDA Seeks Comments on ‘Behind-the-Counter’ Drug Sales
Oct 5, 2007 8:00 AM
WASHINGTON — “Behind-the-counter” sales of certain drugs — that is, sold by pharmacists without a prescription — are being considered by the Food and Drug Administration, according to a notice published in the Federal Register yesterday. A public meeting is scheduled for Nov. 14. This type of drug sale has been mentioned by retailers — and some say it is already in place with the emergency contraceptive Plan B and the decongestant pseudoephedrine — but FDA said this week it is seeking public comment on making more medicines available this way. Birth control and cholesterol-lowering drugs have been mentioned.
Read More of Today's Headlines
Subscribe / Renew to Supermarket News
The most reliable source of industry news and insight...in print and online.
- Subscribe Today and gain instant access to the online SN Archive
- Renew
- Sign up for email newsletter
advertisement
Most Viewed News
Retail Analytics
Brian Ross
In This Week's Viewpoints
Dan Alaimo:
The Pace of Change Challenges Food Retailers












